147 related articles for article (PubMed ID: 20851254)
1. Misoprostol use in the community to reduce maternal death.
Gülmezoglu AM; Mathai M; Souza JP; d'Arcangues C; Mbizvo M
Lancet; 2010 Sep; 376(9745):955; author reply 955-6. PubMed ID: 20851254
[No Abstract] [Full Text] [Related]
2. Questions raised over use of misoprostol to prevent postpartum haemorrhage in poor countries.
Torjesen I
BMJ; 2012 Aug; 345():e5715. PubMed ID: 22932982
[No Abstract] [Full Text] [Related]
3. Misoprostol use in the community to reduce maternal death.
Winikoff B; Blum J
Lancet; 2010 Sep; 376(9745):954-5; author reply 955-6. PubMed ID: 20851251
[No Abstract] [Full Text] [Related]
4. Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin.
Buekens P; Althabe F
Lancet; 2010 Jan; 375(9710):176-8. PubMed ID: 20109901
[No Abstract] [Full Text] [Related]
5. Treatment of postpartum hemorrhage with misoprostol.
International Federation Of Gynecology And Obstetrics
Int J Gynaecol Obstet; 2012 Dec; 119(3):215-6. PubMed ID: 23036964
[No Abstract] [Full Text] [Related]
6. Should we be using misoprostol to prevent postpartum haemorrhage?
Pract Midwife; 2013 May; 16(5):9. PubMed ID: 23789247
[No Abstract] [Full Text] [Related]
7. Prevention of postpartum hemorrhage with misoprostol.
International Federation Of Gynecology and Obstetrics
Int J Gynaecol Obstet; 2012 Dec; 119(3):213-4. PubMed ID: 23022109
[No Abstract] [Full Text] [Related]
8. Maternal mortality: one death every 7 min.
Potts M; Prata N; Sahin-Hodoglugil NN
Lancet; 2010 May; 375(9728):1762-3. PubMed ID: 20494713
[No Abstract] [Full Text] [Related]
9. Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial.
Mansouri HA; Alsahly N
Arch Gynecol Obstet; 2011 May; 283(5):935-9. PubMed ID: 20422423
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
[TBL] [Abstract][Full Text] [Related]
11. [Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)].
Nielsen BB; Høj L; Hvidman LE; Nielsen J; Cardoso P; Aaby P
Ugeskr Laeger; 2006 Mar; 168(13):1341-3. PubMed ID: 16579891
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol for the prevention and treatment of postpartum haemorrhage.
Hofmeyr GJ; Gülmezoglu AM
Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1025-41. PubMed ID: 18786863
[TBL] [Abstract][Full Text] [Related]
13. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.
Hofmeyr GJ; Gülmezoglu AM; Novikova N; Linder V; Ferreira S; Piaggio G
Bull World Health Organ; 2009 Sep; 87(9):666-77. PubMed ID: 19784446
[TBL] [Abstract][Full Text] [Related]
14. Overcoming entrenched disagreements: the case of misoprostol for post-partum haemorrhage.
Ghinea N; Lipworth W; Little M; Kerridge I; Day R
Dev World Bioeth; 2015 Apr; 15(1):48-54. PubMed ID: 25897445
[TBL] [Abstract][Full Text] [Related]
15. New global guidance supports community and lay health workers in postpartum hemorrhage prevention.
Ejembi CL; Norick P; Starrs A; Thapa K
Int J Gynaecol Obstet; 2013 Sep; 122(3):187-9. PubMed ID: 23796260
[TBL] [Abstract][Full Text] [Related]
16. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment.
Rajan PV; Wing DA
Clin Obstet Gynecol; 2010 Mar; 53(1):165-81. PubMed ID: 20142654
[TBL] [Abstract][Full Text] [Related]
17. How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention?
Lovold A; Stanton C; Armbruster D
Int J Gynaecol Obstet; 2008 Dec; 103(3):276-82. PubMed ID: 18954869
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
Starrs A; Winikoff B
Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
[TBL] [Abstract][Full Text] [Related]
19. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.
Afolabi EO; Kuti O; Orji EO; Ogunniyi SO
Singapore Med J; 2010 Mar; 51(3):207-11. PubMed ID: 20428741
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol for third stage of labour.
el-Refaey H; O'Brien P; Morafa W; Walder J; Rodeck C
Lancet; 1996 May; 347(9010):1257. PubMed ID: 8622464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
